Ken Griffin Coll Plant Biotechnologies LTD Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 200 shares of CLGN stock, worth $994. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 1,800
88.89%
Holding current value
$994
Previous $11,000
90.91%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLGN
# of Institutions
16Shares Held
1.88MCall Options Held
200Put Options Held
500-
Pinnacle Associates LTD530KShares$2.64 Million0.05% of portfolio
-
Investment Management Of Virginia LLC464KShares$2.31 Million0.63% of portfolio
-
Villere St Denis J & CO LLC367KShares$1.82 Million0.17% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD315KShares$1.57 Million3.45% of portfolio
-
Brown Advisory Inc120KShares$594,0930.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $55.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...